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Guanylyl cyclases (GCs), the
enzymes that synthesize cyclic GMP
(cGMP), have classically been
divided into two groups: receptor
GCs and soluble GCs. Receptor GCs
are integral membrane proteins such
as the retinal guanylyl cyclases and
the atrial natriuretic peptide
receptors. Soluble GCs are
heterodimeric proteins consisting of
an α and a β subunit that bind a
heme group and are activated by
nitric oxide (NO) [1]. 
The recent publication of the
Caenorhabditis elegans genomic
sequence has revealed an
unexpected abundance of GCs.
There seem to be at least 26
receptor GC genes [2,3], compared
to the 7 that have been identified so
far in mammals. In addition, there
are at least 7 genes that are similar
to soluble GCs, which is particularly
surprising, as there does not appear
to be a gene for NO synthase.
Closer examination of the soluble
GC sequences reveals further
unusual characteristics. BLAST
analysis of each sequence suggests
that they are more similar to β
subunits than to α subunits, and a
phylogenetic tree analysis places
five of them in a separate cluster
that includes the rat β2 subunit and
places the others in an additional
grouping (see Figure 1a). 
Several studies have identified
amino acid residues in mammalian
β subunits that are important for
either heme binding or activation by
NO. His105 (in the numbering of the
rat β1 subunit sequence), which has
been identified as the likely axial
ligand of the heme moiety and is
critical for NO activation [4], is
conserved in all the C. elegans soluble
GCs (Figure 1b). Two other
important residues are the cysteines
at positions 78 and 214. When these
are mutated to serines and the
resulting mutant β subunit is
co-expressed with a wild-type
α subunit, the resulting enzyme is
NO-insensitive and binds heme with
a low affinity [5]. Both of these
cysteines are absent in all of the
C. elegans sequences, suggesting that
none of these proteins is able to
respond to NO. 
Direct evidence for this comes
from two sources. First, the cloning
of a novel GC β subunit, MsGC-β3,
from the insect Manduca sexta has
recently been reported [6]; like all of
the C. elegans sequences, it lacks
Cys78 and Cys214 but contains a
histidine homologous to His105.
When MsGC-β3 was expressed in
heterologous cells, it was, indeed,
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Figure 1
(a) Phylogenetic tree of the soluble guanylyl
cyclases (GCs). Amino acid sequences were
taken from Genbank, aligned with ClustalW
and the phylogenetic tree drawn using
Dendromaker . (b) Sequence alignment of
the GC β subunits and the seven C. elegans
soluble GCs, showing the regions
surrounding His105, Cys78 and
Cys214 (numbers based on the rat β1
cyclase sequence). Abbreviations: MsGC,
Manduca sexta GC; DmGC, Drosophila
melanogaster GC; MusGC, mouse GC;
HumGC, human GC; BovGC, bovine GC;
MedGC, Medaka fish GC; CeGC,
C. elegans GC. The C. elegans GCs are
encoded by the following loci: CeGC1,
T04D3; CeGC2, C06B3; CeGC3,
M04G12; CeGC4, F57F5 and C52E4;
CeGC5, C54E4; CeGC6, C46E1 and
H13N06; and CeGC-β3, T07D1 [6].
(a) (b)
Cys78 His105 Cys214
MsGC-β1 76 EFCQDSGYDK----------ILQVLGATPRDFLQNLDGLHDHLG 109 201 LEPKVSPATFCRVFP 216
DmGC-β 76 EFCQDSGYDK----------ILQVLGATPRDFLQNLDALHDHLG 109 323 EAPLISPATFCKVFP 338
RatGC-β1 76 VFCQESGYDT----------ILRVLGSNVREFLQNLDALHDHLA 109 203 QDSRISPYTFCKAFP 218
MusGC-β1 76 VFCQESGYDT----------ILRVLGSNVREFLQNLDALHDHLA 109 203 QESRISPYTFCKAFP 218
HumGC-β1 76 VFCQESGYDT----------ILRVLGSNVREFLQNLDALHDHLA 109 203 QESRISPYTFCKAFP 218
BovGC-β1 76 VFCQESGYDT----------ILRVLGSNVREFLQNLDALHDHLA 109 203 QESRISPYTFCKAFP 218
MedGC-β 76 EFCQESGYDT----------ILRVLGSNVREFLQNLDALHDHLG 109 203 QETRISPYTFCKAFP 218
MsGC-β3 75 GFVSQYGYDR----------VLSVLGRHMRDFLNGLDNLHEYLK 108 198 KHLPISASVLFEIFP 213
CeGC-β3 75 KFLTKFEFNKVYYVLFYIPYVLRVLGRTFPQFLNGLDNLHEYLR 118 212 EKVKITSDIFFDIFP 227
CeGC4 75 QFLIRNGYGD----------LMNVMGRRFSDFIKGLDNIHEYFR 108 201 EYLPVDTKSFLQMFP 216
CeGC1 76 QFTMETGWDE----------LLRAMAPDLEGFLDSLDSLHYFID 109 213 GIYEISSSDFSLAFP 228
CeGC5 69 THACETGWQK----------MLFCMANNLQEFLDNLNSMHYFID 103 212 STILVGLRDFKNIFP 227
CeGC2 76 TYSMEIGWDE----------LVRSMSPNLKGFLDNLDSLHYFID 109 236 DTLGISLDDFSKALP 251
CeGC3 76 TYSMEIGWDE----------LVRSMSPNLKGFLDNLDSLHYFID 109 221 DNLKVSLQDFSRALP 236
CeGC6 86 TYTMETGWDD----------LIRSMSPNLKGFLDNLDSLHYFID 119 225 YKIRLTHMDFISTFP 240
RatGC-β2
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insensitive to NO. A surprising
finding was that MsGC-β3 did not
need to form heterodimers and was
active without co-expression of
additional subunits [6]. If the
C. elegans GCs share this property, it
might explain the lack of α subunits
in C. elegans. The second line of
evidence comes from direct
measurements of GC activity in
homogenates of C. elegans where,
although a basal level of activity was
detected, no NO-stimulated activity
was measured [7]. 
A major question that remains to
be resolved is how these GCs are
activated, but these findings do
provide strong evidence for the
activation of soluble GCs in C. elegans
by a novel, NO-independent
mechanism.
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Primate evolution — in
and out of Africa
Comments from
Salvador Moyà-Solà,
Meike Köhler and David
M. Alba
Stewart and Disotell [1] construct a
scenario for the evolutionary history
of catarrhine primates that they
believe to be “robust about the exact
phylogenetic positions of the
Eurasian hominoid fossils”, and
parsimonious in that it requires a
minimum number of dispersal
events. The authors present a
synthesis of the known molecular
phylogeny of the living species and
parsimony analyses of fossils, and
map the biogeographical locations of
the living and fossil species onto this
phylogeny. Stewart and Disotell
conclude that “the lineage leading to
the living hominoids dispersed out of
Africa about twenty million years
ago, and that the common ancestor of
the living African apes, including
humans, migrated back into Africa
from Eurasia within about the past
ten million years.”
We think that multi-disciplinary
analyses involving data from different
fields such as molecular biology,
biogeography and paleontology are
useful, and even necessary, to reliably
reconstruct the evolutionary history
of a phylogenetic entity, and we
applaud this approach. Nevertheless,
it is a standard procedure in scientific
analyses to verify whether the
hypothesis is consistent with the
known data.
In this case, the proposed
scenario B is not consistent with the
fossil record. In Eurasia, Miocene
faunas are documented from
hundreds of rich localities, and the
first appearances of the different
primate groups are well dated [2,3].
No catarrhine primate is known from
any site older than 16 million years
ago, despite faunal, floral and
sedimentological testimonies of
environmental conditions suitable for
hominoids. The oldest Asian
catarrhine (16.1 million years ago) is
Dionysopithecus, a hominoid without
clear affinities to either hylobatids,
orangutans or African apes [4]. The
oldest European catarrhines, the
non-hominoid pliopithecids and the
primitive hominoid Griphopithecus,
first appeared between 15.5 and
15 million years ago [2]. Thus, an
‘out of Africa’ dispersal of hominoids
at 20 million years ago must be
discarded.
Taking into account the age of
the lesser ape / great ape dichotomy
provided by molecular data as
roughly 18 million years ago, it seems
more reasonable to assume two
dispersals into Eurasia, one of the
hylobatids at about 16 million years
ago and another of the Eurasian great
ape ancestor between 13 and
12 million years ago. In fact, a third
event took place, when Griphopithecus
— a descendant of Kenyapithecus and
probably not related to the younger
Eurasian apes — dispersed into
Eurasia about 15.5 million years ago.
The gap in the African fossil
record between 12 and 6.5 million
years ago does not indicate a putative
extinction of the African hominoid
lineages, but is likely to be an
artifact. Extant hominoids and
almost all fossil hominoids have a
pantropical distribution; fossils from
tropical environments are scarce.
Unlike the large record from
Eurasian localities, the African
Upper Miocene–Lower Pliocene
record is poor, most likely because of
the difficulties of sampling in the
areas where these fossil hominoids
probably lived. Thus, the survival of
one or more hominoid lineages in
Africa during the Upper Miocene is
likely and an African origin of the
African ape and human clade must
be considered.
Given that the well-sampled
Eurasian fossil record is not
consistent with a Eurasian origin of
the lesser and great ape lineages,
scenario B proposed by Stewart and
Disotell must be ruled out, as it
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